Alzheimer’s disease preventative nasal vaccine to be tested at Boston hospital
Fox News
Boston's Brigham and Women’s Hospital announced Tuesday that it would test a nasal vaccine for Alzheimer’s disease.
"The launch of the first human trial of a nasal vaccine for Alzheimer’s is a remarkable milestone," Dr. Howard Weiner, co-director of the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital, said in a statement. "If clinical trials in humans show that the vaccine is safe and effective, this could represent a nontoxic treatment for people with Alzheimer’s, and it could also be given early to help prevent Alzheimer’s in people at risk."
The first human clinical trial for the intranasal vaccine is intended to prevent and slow the progression of the disease.
More Related News